Cite
MLA Citation
Jerold Jeyaratnam et al.. “Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.” Rheumatology, vol. 61, 2022, pp. 2088–2094. http://access.bl.uk/ark:/81055/vdc_100154244633.0x000024